<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	
	>
<channel>
	<title>
	Commenti a: Orteq® Sports Medicine Announces Publication of 5-year Multi-Center Clinical Data for the Actifit® Meniscal Scaffold in the American Journal of Sports Medicine (AJSM), Receives FDA Breakthrough Device Designation 	</title>
	<atom:link href="https://www.newpharmaitaly.it/orteq-sports-medicine-announces-publication-of-5-year-multi-center-clinical-data-for-the-actifit-meniscal-scaffold-in-the-american-journal-of-sports-medicine-ajsm-receives-fda-breakthro/feed/" rel="self" type="application/rss+xml" />
	<link>https://www.newpharmaitaly.it/orteq-sports-medicine-announces-publication-of-5-year-multi-center-clinical-data-for-the-actifit-meniscal-scaffold-in-the-american-journal-of-sports-medicine-ajsm-receives-fda-breakthro/</link>
	<description>Il portale delle news in ambito farmaceutico</description>
	<lastBuildDate>Mon, 25 May 2020 22:00:59 +0000</lastBuildDate>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0.2</generator>
</channel>
</rss>
